WHO ICTRP trial
Topical Miotic Administered by the AcuStream Delivery System in Subjects with…
ACTRN12619001325190 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12619001325190 |
|---|---|
| Public title | Topical Miotic Administered by the AcuStream Delivery System in Subjects with Presbyopia |
| Scientific title | A Double-Masked, Randomised Study of a Topical Miotic Administered by the AcuStream Delivery System on Near Visual Acuity in Subjects with Age-Related Presbyopia |
| Primary sponsor | Kedalion Therapeutics Australia Pty Ltd |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Australia |
| Conditions | Presbyopia; Presbyopia;Eye - Diseases / disorders of the eye |
| Interventions | Dose: KT-101 will be self-administered by patients as a single, topical microdose (10ul) in 3 concentrations (1%, 2% and 4%) along with a placebo controlled arm. Adherence will be monitored through physician observation and record in… |
| Registration date | Sep 27, 2019 |
| Target size | 60 |
| Secondary IDs | KT-101-02 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: